| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-20 | Ma Stephen Hoi CFO, COO and Secretary | Purchase | +650,000 | +100.00%650,000 | $0.15 | $99,970 | View SEC filing | |
| 2026-04-20 | Ji Henry Exec Chair, CEO and President | Mixed | +2,600,000 | +100.00%2,600,000 | $0.15 | $599,820 | View SEC filing | |
| 2025-12-30 | Scilex Holding Co 10% Owner | Sale | -20,657,300 | -7.79%244,445,260 | $0.62 | $12,771,580 | View SEC filing | |
| 2024-12-18 | SHAH JAISIM See Remarks | Purchase | +30,000 | +27.44%139,333 | $0.46 | $13,800 | View SEC filing | |
| 2024-10-31 | Ji Henry Executive Chairperson | Purchase | +8,888 | +2.86%320,161 | $0.94 | $8,351 | View SEC filing | |
| 2024-10-29 | SHAH JAISIM See Remarks | Purchase | +32,000 | +41.38%109,333 | $0.99 | $31,670 | View SEC filing | |
| 2024-10-18 | Followwill Dorman Director | Purchase | +1,000 | +76.92%2,300 | $0.99 | $990 | View SEC filing | |
| 2024-10-18 | Chun Jay Director | Purchase | +5,000 | +4.65%112,500 | $0.95 | $4,750 | View SEC filing | |
| 2024-10-18 | Wu Yue Alexander Director | Purchase | +20,000 | +400.00%25,000 | $0.95 | $18,992 | View SEC filing | |
| 2024-10-18 | Lemus David Director | Purchase | +2,000 | +100.00%2,000 | $0.90 | $1,800 | View SEC filing | |
| 2024-10-18 | Ji Henry Executive Chairperson | Purchase | +10,000 | +19.97%60,070 | $0.97 | $9,710 | View SEC filing | |
| 2024-10-17 | SHAH JAISIM See Remarks | Purchase | +30,000 | +63.38%77,333 | $0.99 | $29,751 | View SEC filing | |
| 2024-10-17 | Ma Stephen Hoi Chief Financial Officer | Purchase | +6,700 | +41.51%22,840 | $0.97 | $6,499 | View SEC filing | |
| 2024-05-17 | Ji Henry Executive Chairperson | Purchase | +50,000 | +71428.57%50,070 | $0.88 | $43,985 | View SEC filing | |
| 2024-05-17 | Chun Jay Director | Purchase | +57,500 | +127.78%102,500 | $0.90 | $51,641 | View SEC filing | |
| 2024-05-17 | SHAH JAISIM See Remarks | Purchase | +140,000 | +881.50%155,882 | $0.87 | $121,945 | View SEC filing | |
| 2024-05-17 | Ma Stephen Hoi Chief Financial Officer | Purchase | +14,140 | +100.00%14,140 | $0.88 | $12,443 | View SEC filing | |
| 2023-09-25 | Sorrento Therapeutics, Inc. 10% Owner | Sale | -64,559,202 | -97.12%1,917,210 | N/A | N/A | View SEC filing | |
| 2022-12-02 | Sorrento Therapeutics, Inc. 10% Owner | Purchase | +224,841 | +5.27%4,490,617 | $0.35 | $78,852 | View SEC filing | |
| 2022-11-25 | Sorrento Therapeutics, Inc. 10% Owner | Purchase | +46,172 | +1.09%4,265,776 | $0.44 | $20,196 | View SEC filing | |
| 2022-11-23 | Sorrento Therapeutics, Inc. 10% Owner | Purchase | +442,829 | +11.73%4,219,604 | $0.40 | $175,670 | View SEC filing | |
| 2022-11-22 | Sorrento Therapeutics, Inc. 10% Owner | Purchase | +672,775 | +21.67%3,776,775 | $0.23 | $152,047 | View SEC filing |
1-22 of 22
